Curetis Reports Financial Results for the First Six Months of 2019

NEXT STORY
Summit Announces Publication of Editorial in Future Microbiology Advocating for Innovation in Antibiotic Development to Drive Stewardship Focus on Improving Patient Outcomes
PREV STORY
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
Subscribe to PM360
Print Subscription

Experts on Call

Follow Us
Get in touch with PM360 Experts On Call

Ads

You May Also Like

FIT Biotech Oy: FIT Biotech Oy’s Board of Directors has decided on the issue of Convertible Notes and Warrants

FIT Biotech Oy Company release February 14, 2018 at 5:45 pm EET FIT Biotech ...

author_avatar
NASDAQ Market News

Lexicon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides a Business Update

XERMELO® (telotristat ethyl) Quarterly U.S. Net Sales of $5.4 Million Filings Submitted for Regulatory ...

author_avatar
NASDAQ Market News

Landmark Health Hosts Grand Opening

ALBANY, N.Y., June 24, 2016 (GLOBE NEWSWIRE) -- House calls are making a comeback ...

author_avatar
NASDAQ Market News